Sensei Biotherapeutics, Inc. financial data

Symbol
SNSE on Nasdaq
Location
Rockville, MD
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 700% % -36%
Debt-to-equity 18% % 25%
Return On Equity -80% % -49%
Return On Assets -68% % -44%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,261,290 shares -95%
Common Stock, Shares, Outstanding 1,261,290 shares -95%
Common Stock, Value, Issued $0 USD -100%
Weighted Average Number of Shares Outstanding, Basic 1,261,290 shares 0.32%
Weighted Average Number of Shares Outstanding, Diluted 1,261,290 shares 0.32%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $11,371,000 USD -18%
Operating Income (Loss) $25,605,000 USD 21%
Net Income (Loss) Attributable to Parent $24,139,000 USD 19%
Earnings Per Share, Basic 2 USD/shares 37%
Earnings Per Share, Diluted 2 USD/shares 37%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $10,562,000 USD -45%
Other Assets, Current $248,000 USD 206%
Assets, Current $25,785,000 USD -46%
Property, Plant and Equipment, Net $112,000 USD -88%
Operating Lease, Right-of-Use Asset $1,668,000 USD -48%
Other Assets, Noncurrent $18,000 USD -79%
Assets $27,589,000 USD -48%
Accounts Payable, Current $306,000 USD
Employee-related Liabilities, Current $1,156,000 USD -13%
Accrued Liabilities, Current $1,019,000 USD
Liabilities, Current $4,436,000 USD -18%
Operating Lease, Liability, Noncurrent $146,000 USD -92%
Liabilities $4,582,000 USD -39%
Accumulated Other Comprehensive Income (Loss), Net of Tax $3,000 USD -121%
Retained Earnings (Accumulated Deficit) $278,421,000 USD -9.5%
Stockholders' Equity Attributable to Parent $23,007,000 USD -50%
Liabilities and Equity $27,589,000 USD -48%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 12,500,000 shares -95%
Common Stock, Shares, Issued 1,261,290 shares -95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Operating Lease, Liability $1,828,000 USD -47%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $24,156,000 USD 18%
Lessee, Operating Lease, Liability, to be Paid $1,900,000 USD -49%
Property, Plant and Equipment, Gross $622,000 USD -80%
Operating Lease, Liability, Current $1,682,000 USD 4.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $59,000 USD -96%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,413,000 USD -19%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $72,000 USD -73%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $1,370,000 USD -64%
Interest Expense $46,000 USD -56%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%